VANCOUVER, British Columbia, Oct. 14, 2011 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued Equity Research for top traded penny stocks: Vista Gold (AMEX:VGZ), Rare Element Resources (Canada) (AMEX:REE), PharmAthene (AMEX:PIP). More reports for Apple (NASDAQ:AAPL), American Capital (NASDAQ:ACAS) & Tyco International (NYSE:TYC).
Many day trade speculators are interested to buy top penny stocks because of this market's huge daily price volatility. Stock speculators may also investigate to see if there are any significant insider trading activities in the most active penny stocks. Insiders who have access to confidential company information and are involved in making daily business decisions are best positioned to predict the future price of their company's shares.
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Research Report Highlights:
Vista Gold Corp. (AMEX:VGZ): Company Directors Sold Stock Shares
Insider Trade Signals: Vista Gold Corp. is engaged in the evaluation, acquisition, exploration and advancement of gold exploration and development projects. Today's stock price dropped 4.75% to $3.41. PSI found company directors sold stock shares prior to the low price coming. Want to know how much better returns these insiders are seeing?
Read Full Report: http://www.Pennystocksinsiders.com/PR/101411A/VGZ/VistaGold.pdf
Rare Element Resources Ltd. Ordinary Shares (Canada) (AMEX:REE): Could You Gain Profit From Rare Earth Stocks?
Insider Trade Signals: Rare earths are used in aerospace and technology applications, from semiconductors, to nuclear batteries, to lasers, so they are crucial to a high-tech economy. China recently reported that it largely shut down its rare earth industry for three months to address pollution problems, which resulted in the huge spike in rare earth element prices this summer. Company insiders' activities were found and listed on PSI. Want to know when insiders start selling? Get an email alert for the latest insider buying/selling by subscribing for free below.
PharmAthene, Inc. (AMEX:PIP): Stock Options Granted by Company Insiders
Insider Trade Signals: PharmAthene, Inc. today announced that it has filed its legal brief in response to SIGA Technologies' motion for reargument. On September 22, 2011 PharmAthene announced that the Delaware Court of Chancery had issued a ruling in its litigation against SIGA and awarded PharmAthene 50% of the net profits over 10 years from all sales of ST-246 and related products after SIGA receives the first $40 million in net profits. Do you know when company insiders granted their stock options at this time? Want to find out if insiders are trading at the same time and same direction?
Read Full Report: http://www.Pennystocksinsiders.com/PR/101411A/PIP/PharmAthene.pdf
Today Pennystocksinsiders.com also released other research reports for:
Apple Inc. (NASDAQ:AAPL)
Read Full Report: http://www.Pennystocksinsiders.com/PR/101411A/AAPL/Apple.pdf
American Capital Ltd. (NASDAQ:ACAS)
Read Full Report: http://www.Pennystocksinsiders.com/PR/101411A/ACAS/AmericanCapital.pdf
Tyco International Ltd. (NYSE:TYC)
Read Full Report: http://www.Pennystocksinsiders.com/PR/101411A/TYC/Tyco.pdf
More Individual Stock Reports & Sector Reports:
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit http://www.Pennystocksinsiders.com/disclaimers/index.php for details.